Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose Finding of Inhaled Glycopyrronium Bromide in COPD
NCT01703624Phase 2Completed
- Sponsor
- Prosonix
- Start
- May 2013
- Primary completion
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of glycopyrronium in chronic obstructive pulmonary disease (COPD), sponsored by Prosonix. Started May 2013; status: completed.
02
Drugs
glycopyrronium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01703624.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01703624.